Latest Breaking News On - Patients with refractory myasthenia - Page 1 : comparemela.com

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced it.

United statesPeter maagChristian pflaumerKyverna therapeutics incDrug administrationNational institutes of healthTrack designationPatients with refractory myastheniaKyverna therapeuticsNational institutesMedia contactNature medicine